Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04626869
Other study ID # 2020.1234
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date December 1, 2020
Est. completion date April 1, 2021

Study information

Verified date November 2021
Source V.K.V. American Hospital, Istanbul
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Interscalene block is still the gold standard in shoulder surgery analgesia. The most important side effect is diaphragm paralysis due to the phrenic nerve being affected. It may cause symptomatic dyspnea, especially in patients with limited respiratory capacity. There are studies showing that an effective analgesia, as much as the interscalene block can do, can be provided by blocking the suprascapular nerve in the neck region. The aim of our study is to show that the anterior suprascapular block applied with ultra-low volume (5ml) in shoulder arthroscopy operations is at least as effective as the interscalene block and does not cause diaphragm paralysis.


Description:

Interscalene block is still the gold standard in shoulder surgery analgesia. The most important side effect is diaphragm paralysis due to the phrenic nerve being affected. It may cause symptomatic dyspnea, especially in patients with limited respiratory capacity. More distal brachial plexus blocks have been defined to avoid diaphragmatic paralysis . Thus, it is aimed to apply the local anesthetic drug further from the phrenic nerve. With the application of ultrasound, the amount of local anesthetic drug was reduced to less than 20 ml. There are studies showing that an effective analgesia, as much as the interscalene block can do, can be provided by blocking the suprascapular nerve in the neck region. Although it has been shown in a cadaver study that the phrenic nerve can be stained after anterior suprascapular nerve block, the clinical effect is not fully known. The effect of continuous local anesthetic drug administration on respiratory muscles through catheters placed in the peripheral nerve is another matter of concern. The method that will not affect the phrenic nerve at all and at the same time provide an effective analgesia is still under investigation. The aim of our study is to show that the anterior suprascapular block applied with ultra-low volume (5ml) in shoulder arthroscopy operations is at least as effective as the interscalene block and does not cause diaphragm paralysis. One of the questions that our research aims to answer is how the continuous application of local anesthetic drugs affects the diaphragm muscle with the insertion of catheters in both regions.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date April 1, 2021
Est. primary completion date March 15, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - Patients > 18 years old - American Society of Anesthesiology (ASA) score of 1-3 - Scheduled for elective surgery. Exclusion Criteria: - Patients with a condition that prevents peripheral nerve block - Coagulopathies - Chronic opioid use - Stroke - Polyneuropathy - Cognitive dysfunction - Communication difficulties - Allergies to drugs used

Study Design


Related Conditions & MeSH terms

  • Analgesia, Arthroscopic Shoulder Surgery
  • Anterior Suprascapular Nerve Block
  • Diaphragm Paralysis Due to Local Anesthesia
  • Paralysis
  • Respiratory Paralysis

Intervention

Other:
Evaluation of Diaphragm Movement
Diaphragmatic movement will be evaluated with ultrasonography and a 5-2 MHz convex transducer will be used. The ultrasound probe is placed between the mid-clavicular line and the anterior axillary line by directing it vertically and slightly cranially. During quiet breathing and deep breathing, diaphragm movement will be measured. The reduction in diaphragm motion will be calculated as the difference (in percent) in diaphragm motion measured before and 30 minutes after the block. Each test will be done 3 times and the values will be averaged. A decrease between 75% and 100% will be defined as complete paresis, a decrease between 25% and 75% as partial paresis, and less than 25% decrease in diaphragmatic movement will be defined as no paresis. In order to investigate the effect of continuous local anesthetic drug administration on diaphragm movement via nerve catheter, the same procedure will be repeated 24 hours after surgery.

Locations

Country Name City State
Turkey VKV Amerikan Hastanesi Istanbul Sisli

Sponsors (1)

Lead Sponsor Collaborator
Alper Tunga Dogan

Country where clinical trial is conducted

Turkey, 

References & Publications (4)

Auyong DB, Hanson NA, Joseph RS, Schmidt BE, Slee AE, Yuan SC. Comparison of Anterior Suprascapular, Supraclavicular, and Interscalene Nerve Block Approaches for Major Outpatient Arthroscopic Shoulder Surgery: A Randomized, Double-blind, Noninferiority Tr — View Citation

Bansal V, Shastri U, Canlas C, Gadsden JC. Diaphragm-Sparing Nerve Blocks for Shoulder Surgery: An Alternative Approach. Reg Anesth Pain Med. 2017 Jul/Aug;42(4):544-545. doi: 10.1097/AAP.0000000000000606. — View Citation

Tran DQ, Layera S, Bravo D, Cristi-Sanchéz I, Bermudéz L, Aliste J. Diaphragm-sparing nerve blocks for shoulder surgery, revisited. Reg Anesth Pain Med. 2019 Sep 20. pii: rapm-2019-100908. doi: 10.1136/rapm-2019-100908. [Epub ahead of print] — View Citation

Wiegel M, Moriggl B, Schwarzkopf P, Petroff D, Reske AW. Anterior Suprascapular Nerve Block Versus Interscalene Brachial Plexus Block for Shoulder Surgery in the Outpatient Setting: A Randomized Controlled Patient- and Assessor-Blinded Trial. Reg Anesth P — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Pain rating Measured by VAS. Postoperative 30 minutes the first postoperative 30 minutes
Primary Pain rating Measured by VAS. Postoperative 6 hours Postoperative 6 hours
Primary Pain rating Measured by VAS. Postoperative 12 hours Postoperative 12 hours
Secondary Diaphragmatic movements Diaphragmatic movement will be evaluated with ultrasound. 30 minutes after the block application. 30 minutes after the block application.
Secondary Diaphragmatic movements Diaphragmatic movement will be evaluated with ultrasound. 24 hours after the block application. At the first postoperative 24 hours
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06146179 - Combined Anterior Suprascapular Nerve Block and Superficial Cervical Plexus Block In Shoulder Arthroplasty Surgery
Completed NCT05442814 - Anterior and Posterior Approaches of Suprascapular Nerve Block N/A
Recruiting NCT05739201 - ISB, SSNB, and PENG Block for Arthroscopic Shoulder Surgery N/A